IXICO PLC - ESG Rating & Company Profile powered by AI
The webpage includes a questions and answers section for IXICO PLC. Other corporations in the scoring peer group for IXICO PLC are shownin the table. If you work at IXICO PLC and you wish to licence your ESG aseessment, please contact us.
IXICO PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | IXICO PLC | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does IXICO PLC have an accelerator or VC vehicle to help deliver innovation?
Does IXICO PLC disclose current and historical energy intensity?
Does IXICO PLC report the average age of the workforce?
Does IXICO PLC reference operational or capital allocation in relation to climate change?
Does IXICO PLC disclose its ethnicity pay gap?
Does IXICO PLC disclose cybersecurity risks?
Does IXICO PLC offer flexible work?
Does IXICO PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does IXICO PLC disclose the number of employees in R&D functions?
Does IXICO PLC conduct supply chain audits?
Does IXICO PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does IXICO PLC conduct 360 degree staff reviews?
Does IXICO PLC disclose the individual responsible for D&I?
Does IXICO PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does IXICO PLC disclose current and / or historical scope 2 emissions?
Does IXICO PLC disclose water use targets?
Does IXICO PLC have careers partnerships with academic institutions?
Did IXICO PLC have a product recall in the last two years?
Does IXICO PLC disclose incidents of discrimination?
Does IXICO PLC allow for Work Councils/Collective Agreements to be formed?
Has IXICO PLC issued a profit warning in the past 24 months?
Does IXICO PLC disclose parental leave metrics?
Does IXICO PLC disclose climate scenario or pathway analysis?
Does IXICO PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does IXICO PLC disclose the pay ratio of women to men?
Does IXICO PLC support suppliers with sustainability related research and development?
Does IXICO PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does IXICO PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is IXICO PLC involved in embryonic stem cell research?
Does IXICO PLC disclose GHG and Air Emissions intensity?
Does IXICO PLC disclose its waste policy?
Does IXICO PLC report according to TCFD requirements?
Does IXICO PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does IXICO PLC disclose energy use targets?
Does IXICO PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does IXICO PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for IXICO PLC
These potential risks are based on the size, segment and geographies of the company.
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.